22 research outputs found

    A5: Grafton Notch State Park: Glacial Gorges and Streams Under Pressure in the Mahoosic Range, Maine

    Get PDF
    Guidebook for field trips in Western Maine and Northern New Hampshire: New England Intercollegiate Geological Conference, p. 95-104

    The Last Glacial Maximum in Central North Island, New Zealand: Palaeoclimate Inferences from Glacier Modelling

    Get PDF
    Quantitative palaeoclimate reconstructions provide data for evaluating the mechanisms of past, natural climate variability. Geometries of former mountain glaciers constrained by moraine mapping afford the opportunity to reconstruct palaeoclimate, due to the close relationship between ice extent and local climate. In this study, we present results from a series of experiments using a 2D coupled energy-balance/ice-flow model that investigate the palaeoclimate significance of Last Glacial Maximum m oraines within nine catchments in the central North Island, New Zealand. We find that the former ice limits can be simulated when present-day temperatures are reduced by between 4 and 7 â—¦C, if precipitation remains unchanged from present. The spread in the results between the nine catchments is likely to rep- resent the combination of chronological and model uncer- tainties. The majority of catchments targeted require tem- perature decreases of 5.1 to 6.3 â—¦ C to simulate the former glaciers, which represents our best estimate of the tempera- ture anomaly in the central North Island, New Zealand, dur- ing the Last Glacial Maximum. A decrease in precipitation of up to 25 % from present, as suggested by proxy evidence and climate models, increases the magnitude of the required temperature changes by up to 0.8 â—¦ C. Glacier model experi- ments using reconstructed topographies that exclude the vol- ume of post-glacial (\u3c 15 ka) volcanism generally increased the magnitude of cooling required to simulate the former ice limits by up to 0.5 â—¦ C. Our palaeotemperature estimates ex- pand the spatial coverage of proxy-based quantitative palaeo- climate reconstructions in New Zealand. Our results are also consistent with independent, proximal temperature recon- structions from fossil groundwater and pollen assemblages, as well as similar glacier modelling reconstructions from the central Southern Alps, which suggest air temperatures were ca. 6 â—¦ C lower than present across New Zealand during the Last Glacial Maximum

    The Last Glacial Maximum in the central North Island, New Zealand: palaeoclimate inferences from glacier modelling

    Get PDF
    Abstract. Quantitative palaeoclimate reconstructions provide data for evaluating the mechanisms of past, natural climate variability. Geometries of former mountain glaciers constrained by moraine mapping afford the opportunity to reconstruct palaeoclimate, due to the close relationship between ice extent and local climate. In this study, we present results from a series of experiments using a 2D coupled energy-balance/ice-flow model that investigate the palaeoclimate significance of Last Glacial Maximum moraines within nine catchments in central North Island, New Zealand. We find that the former ice limits can be simulated when present day temperatures are reduced by between 4 °C and 7 °C, when precipitation remains unchanged from present. The spread in the results between the nine catchments is likely to represent the combination of chronological and model uncertainties. The temperature decrease required to simulate the former glaciers falls in the range of 5.1 °C and 6.3 °C for the majority of catchments targeted, which represents our best estimate of the peak temperature anomaly in central North Island, New Zealand during the Last Glacial Maximum. A decrease in precipitation, as suggested by proxy evidence and climate models, of up to 25 % from present, increases the magnitude of the required temperature changes by up to 0.8 °C. Glacier model experiments using reconstructed topographies that exclude the volume of post-glacial (&lt;15 ka) volcanism, generally increased the magnitude of cooling required to simulate the former ice limits by up to 0.5 °C. Our palaeotemperature estimates expand the spatial coverage of proxy-based quantitative palaeoclimate reconstructions in New Zealand, and are consistent with independent, proximal temperature reconstructions from fossil pollen assemblages, as well as similar glacier modelling reconstructions from central Southern Alps. </jats:p

    Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

    No full text
    Abstract: Background: The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods: This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Findings: Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions: The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown

    Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

    Get PDF
    Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society
    corecore